ask="5.90"
ask_size="200"
average_daily_volume="227432"
bid="5.75"
bid_size="100"
book_value="3.69"
change="-4.15"
change_from_200_day_moving_average="-4.94"
change_from_50_day_moving_average="-5.78"
change_from_52_week_high="-9.00"
change_From_52_week_low="1.72"
change_in_percent="-42.56%"
close="5.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="16060000"
high="7.07"
high_52_weeks="14.60"
last_trade_date="2/2/2017"
last_trade_price="5.60"
last_trade_size="28718"
last_trade_time="4:00pm"
low="5.50"
low_52_weeks="3.88"
market_capitalization="99.94M"
moving_average_200_day="10.54"
moving_average_50_day="11.38"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="6.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-46.88%"
percent_change_from_50_day_moving_average="-50.79%"
percent_change_from_52_week_high="-61.64%"
percent_change_from_52_week_low="+44.33%"
previous_close="9.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.64"
price_per_sales="183.62"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.27"
stock_exchange="NCM"
symbol="STML"
volume="3693033"
weeks_range_52="3.88 - 14.60"
